nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
An ode to the primal tonic of dance—congratulating the Life of Breath project
|
Saketkoo, Lesley Ann |
|
|
8 |
12 |
p. e90-e91 |
artikel |
2 |
Autopsy insights from the EVALI epidemic
|
Blagev, Denitza P |
|
|
8 |
12 |
p. 1165-1166 |
artikel |
3 |
Clinical impact of molecular point-of-care testing for suspected COVID-19 in hospital (COV-19POC): a prospective, interventional, non-randomised, controlled study
|
Brendish, Nathan J |
|
|
8 |
12 |
p. 1192-1200 |
artikel |
4 |
Completion of clinical trials in light of COVID-19
|
Burki, Talha Khan |
|
|
8 |
12 |
p. 1178-1180 |
artikel |
5 |
Confronting a rare ovarian cancer during lockdown
|
Kirby, Tony |
|
|
8 |
12 |
p. 1176-1178 |
artikel |
6 |
Correction to Lancet Respir Med 2020; 8: 709–16
|
|
|
|
8 |
12 |
p. e94 |
artikel |
7 |
COVID-19 among people experiencing homelessness in England: a modelling study
|
Lewer, Dan |
|
|
8 |
12 |
p. 1181-1191 |
artikel |
8 |
COVID-19 human challenge studies in the UK
|
Kirby, Tony |
|
|
8 |
12 |
p. e96 |
artikel |
9 |
COVID-19 transmission—up in the air
|
The Lancet Respiratory Medicine, |
|
|
8 |
12 |
p. 1159 |
artikel |
10 |
Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes
|
Leisman, Daniel E |
|
|
8 |
12 |
p. 1233-1244 |
artikel |
11 |
Dexamethasone in hospitalised patients with COVID-19: addressing uncertainties
|
Matthay, Michael A |
|
|
8 |
12 |
p. 1170-1172 |
artikel |
12 |
Diagnosis of EVALI in the COVID-19 era
|
Kazachkov, Mikhail |
|
|
8 |
12 |
p. 1169-1170 |
artikel |
13 |
Double threat of COVID-19 and influenza
|
Burki, Talha Khan |
|
|
8 |
12 |
p. e97 |
artikel |
14 |
False-positive COVID-19 results: hidden problems and costs
|
Surkova, Elena |
|
|
8 |
12 |
p. 1167-1168 |
artikel |
15 |
Hard to reach: COVID-19 responses and the complexities of homelessness
|
Flook, Mary |
|
|
8 |
12 |
p. 1160-1161 |
artikel |
16 |
Home monitoring for patients with ILD and the COVID-19 pandemic
|
Nakshbandi, G |
|
|
8 |
12 |
p. 1172-1174 |
artikel |
17 |
Near-patient SARS-CoV-2 molecular platforms: new-old tools for new-old problems
|
Moore, Luke S P |
|
|
8 |
12 |
p. 1161-1163 |
artikel |
18 |
Obstructive sleep apnoea: latest surgical advances and considerations during the COVID-19 pandemic
|
Williamson, Lucy |
|
|
8 |
12 |
p. e98 |
artikel |
19 |
Overcoming bleeding events related to extracorporeal membrane oxygenation in COVID-19
|
Asakura, Hidesaku |
|
|
8 |
12 |
p. e87-e88 |
artikel |
20 |
Overcoming bleeding events related to extracorporeal membrane oxygenation in COVID-19 – Authors' reply
|
Schmidt, Matthieu |
|
|
8 |
12 |
p. e89 |
artikel |
21 |
Pathological findings in suspected cases of e-cigarette, or vaping, product use-associated lung injury (EVALI): a case series
|
Reagan-Steiner, Sarah |
|
|
8 |
12 |
p. 1219-1232 |
artikel |
22 |
Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study
|
Grasselli, Giacomo |
|
|
8 |
12 |
p. 1201-1208 |
artikel |
23 |
Physical distancing in schools for SARS-CoV-2 and the resurgence of rhinovirus
|
Poole, Stephen |
|
|
8 |
12 |
p. e92-e93 |
artikel |
24 |
Physiological and biological heterogeneity in COVID-19-associated acute respiratory distress syndrome
|
Ware, Lorraine B |
|
|
8 |
12 |
p. 1163-1165 |
artikel |
25 |
Prevalence of phenotypes of acute respiratory distress syndrome in critically ill patients with COVID-19: a prospective observational study
|
Sinha, Pratik |
|
|
8 |
12 |
p. 1209-1218 |
artikel |
26 |
Provision of holistic care after severe COVID-19 pneumonia: anticipating clinical need and managing resources
|
D'Cruz, Rebecca F |
|
|
8 |
12 |
p. 1175-1176 |
artikel |
27 |
The changing demographics of COVID-19
|
Venkatesan, Priya |
|
|
8 |
12 |
p. e95 |
artikel |